TrialBreast cancer research and treatment2010

Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

Marilyn L Slovak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.